1: Wu CZ, Chu YC, Lai SW, Hsieh MS, Yadav VK, Fong IH, Deng L, Huang CC, Tzeng YM, Yeh CT, Chen JS. Urokinase plasminogen activator induces epithelial- mesenchymal and metastasis of pancreatic cancer through plasmin/MMP14/TGF-β axis, which is inhibited by 4-acetyl-antroquinonol B treatment. Phytomedicine. 2022 Jun;100:154062. doi: 10.1016/j.phymed.2022.154062. Epub 2022 Mar 16. PMID: 35366491.
2: Liu H, Xing H, Jin Y, Liu J, Tzeng YM, Deng L, Wang F. Application of Multiple Strategies to Improve the Production of the Potential Cancer Drug 4-Acetylantroquinonol B (4-AAQB) by the Rare Fungus Antrodia cinnamomea. Appl Biochem Biotechnol. 2022 Mar 8. doi: 10.1007/s12010-022-03811-0. Epub ahead of print. PMID: 35257317.
3: Chen YY, Chen SY, Li TJ, Lin TW, Chen CC, Yen GC. 4-Acetylantroquinonol B enhances cell death and inhibits autophagy by downregulating the PI3K/Akt/MDR1 pathway in gemcitabine-resistant pancreatic cancer cells. Oncol Lett. 2022 Apr;23(4):128. doi: 10.3892/ol.2022.13248. Epub 2022 Feb 18. PMID: 35251348; PMCID: PMC8895450.
4: Chu YC, Tsai TY, Yadav VK, Deng L, Huang CC, Tzeng YM, Yeh CT, Chen MY. 4-Acetyl-Antroquinonol B Improves the Sensitization of Cetuximab on Both Kras Mutant and Wild Type Colorectal Cancer by Modulating the Expression of Ras/Raf/miR-193a-3p Signaling Axis. Int J Mol Sci. 2021 Jul 14;22(14):7508. doi: 10.3390/ijms22147508. PMID: 34299137; PMCID: PMC8307961.
5: Yen IC, Tu QW, Chang TC, Lin PH, Li YF, Lee SY. 4-Acetylantroquinonol B ameliorates nonalcoholic steatohepatitis by suppression of ER stress and NLRP3 inflammasome activation. Biomed Pharmacother. 2021 Jun;138:111504. doi: 10.1016/j.biopha.2021.111504. Epub 2021 Mar 24. PMID: 33773468.
6: Satriyo PB, Su CM, Ong JR, Huang WC, Fong IH, Lin CC, Aryandono T, Haryana SM, Deng L, Huang CC, Tzeng YM, Chao TY, Liu HW, Yeh CT. 4-Acetylantroquinonol B induced DNA damage response signaling and apoptosis via suppressing CDK2/CDK4 expression in triple negative breast cancer cells. Toxicol Appl Pharmacol. 2021 Jul 1;422:115493. doi: 10.1016/j.taap.2021.115493. Epub 2021 Mar 13. PMID: 33727089.
7: Lin TC, Germagian A, Liu Z. The NF-[Formula: see text]B Signaling and Wnt/[Formula: see text]-catenin Signaling in MCF-7 Breast Cancer Cells in Response to Bioactive Components from Mushroom Antrodia Camphorata. Am J Chin Med. 2021;49(1):199-215. doi: 10.1142/S0192415X21500117. Epub 2020 Dec 26. PMID: 33371814.
8: Wu CH, Ou CH, Yen IC, Lee SY. 4-Acetylantroquinonol B Inhibits Osteoclastogenesis by Inhibiting the Autophagy Pathway in a Simulated Microgravity Model. Int J Mol Sci. 2020 Sep 22;21(18):6971. doi: 10.3390/ijms21186971. PMID: 32971944; PMCID: PMC7555662.
9: Chou KC, Wu HL, Lin PY, Yang SH, Chang TL, Sheu F, Chen KH, Chiang BH. 4-Hydroxybenzoic acid serves as an endogenous ring precursor for antroquinonol biosynthesis in Antrodia cinnamomea. Phytochemistry. 2019 May;161:97-106. doi: 10.1016/j.phytochem.2019.02.011. Epub 2019 Feb 26. PMID: 30822625.
10: Liu HW, Su YK, Bamodu OA, Hueng DY, Lee WH, Huang CC, Deng L, Hsiao M, Chien MH, Yeh CT, Lin CM. The Disruption of the β-Catenin/TCF-1/STAT3 Signaling Axis by 4-Acetylantroquinonol B Inhibits the Tumorigenesis and Cancer Stem-Cell-Like Properties of Glioblastoma Cells, In Vitro and In Vivo. Cancers (Basel). 2018 Dec 5;10(12):491. doi: 10.3390/cancers10120491. PMID: 30563094; PMCID: PMC6315804.
11: Li TY, Chiang BH. 4-Acetylantroquinonol B from antrodia cinnamomea enhances immune function of dendritic cells against liver cancer stem cells. Biomed Pharmacother. 2019 Jan;109:2262-2269. doi: 10.1016/j.biopha.2018.11.101. Epub 2018 Nov 28. PMID: 30551483.
12: Bamodu OA, Yang CK, Cheng WH, Tzeng DTW, Kuo KT, Huang CC, Deng L, Hsiao M, Lee WH, Yeh CT. 4-Acetyl-Antroquinonol B Suppresses SOD2-Enhanced Cancer Stem Cell-Like Phenotypes and Chemoresistance of Colorectal Cancer Cells by Inducing hsa-miR-324 re-Expression. Cancers (Basel). 2018 Aug 10;10(8):269. doi: 10.3390/cancers10080269. PMID: 30103475; PMCID: PMC6116152.
13: Liu M, Bamodu OA, Huang WC, Zucha MA, Lin YK, Wu ATH, Huang CC, Lee WH, Yuan CC, Hsiao M, Deng L, Tzeng YM, Yeh CT. 4-Acetylantroquinonol B suppresses autophagic flux and improves cisplatin sensitivity in highly aggressive epithelial cancer through the PI3K/Akt/mTOR/p70S6K signaling pathway. Toxicol Appl Pharmacol. 2017 Jun 15;325:48-60. doi: 10.1016/j.taap.2017.04.003. Epub 2017 Apr 10. PMID: 28408137.
14: Chou KC, Yang SH, Wu HL, Lin PY, Chang TL, Sheu F, Chen KH, Chiang BH. Biosynthesis of Antroquinonol and 4-Acetylantroquinonol B via a Polyketide Pathway Using Orsellinic Acid as a Ring Precursor in Antrodia cinnamomea. J Agric Food Chem. 2017 Jan 11;65(1):74-86. doi: 10.1021/acs.jafc.6b04346. Epub 2016 Dec 21. PMID: 28001060.
15: Chang TC, Yeh CT, Adebayo BO, Lin YC, Deng L, Rao YK, Huang CC, Lee WH, Wu AT, Hsiao M, Wu CH, Wang LS, Tzeng YM. 4-Acetylantroquinonol B inhibits colorectal cancer tumorigenesis and suppresses cancer stem-like phenotype. Toxicol Appl Pharmacol. 2015 Oct 15;288(2):258-68. doi: 10.1016/j.taap.2015.07.025. Epub 2015 Jul 30. PMID: 26235807.